See more : Hamashbir 365 Ltd (MSBI.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Astena Holdings Co., Ltd. (8095.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Astena Holdings Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- AVI Products India Limited (APIL.BO) Income Statement Analysis – Financial Results
- Virco Mfg. Corporation (VIRC) Income Statement Analysis – Financial Results
- UMH Properties, Inc. (UMH-PD) Income Statement Analysis – Financial Results
- UOL Group Limited (U14.SI) Income Statement Analysis – Financial Results
- Tata Consultancy Services Limited (TCS.BO) Income Statement Analysis – Financial Results
Astena Holdings Co., Ltd. (8095.T)
About Astena Holdings Co., Ltd.
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division is involved in the biotechnology related business, such as the provision of drug development support services; and sale of medical equipment. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co.,Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.98B | 49.64B | 72.32B | 65.34B | 61.65B | 60.08B | 57.39B | 55.12B | 55.42B | 54.15B | 52.47B | 51.95B | 53.80B | 50.41B | 47.95B | 50.01B |
| Cost of Revenue | 35.67B | 34.20B | 55.72B | 50.86B | 48.27B | 47.47B | 45.52B | 43.98B | 44.67B | 43.00B | 41.68B | 41.05B | 42.81B | 42.42B | 41.01B | 43.44B |
| Gross Profit | 16.32B | 15.44B | 16.60B | 14.48B | 13.38B | 12.61B | 11.87B | 11.14B | 10.76B | 11.15B | 10.79B | 10.91B | 10.99B | 7.99B | 6.93B | 6.57B |
| Gross Profit Ratio | 31.39% | 31.11% | 22.96% | 22.16% | 21.71% | 20.99% | 20.69% | 20.21% | 19.41% | 20.59% | 20.56% | 21.00% | 20.43% | 15.85% | 14.46% | 13.13% |
| Research & Development | 895.14M | 825.00M | 964.53M | 768.90M | 735.96M | 810.35M | 731.48M | 833.23M | 984.00M | 909.00M | 923.00M | 935.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.05B | 1.92B | 1.90B | 1.73B | 1.95B | 1.84B | 1.74B | 1.64B | 1.73B | 1.69B | 1.61B | 1.61B | 1.70B | 1.42B | 1.28B | 1.18B |
| Selling & Marketing | 983.82M | 988.68M | 745.43M | 853.07M | 942.77M | 899.52M | 1.14B | 1.30B | 1.34B | 1.29B | 1.22B | 1.21B | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.04B | 2.91B | 2.65B | 2.58B | 2.89B | 2.74B | 2.88B | 1.64B | 1.73B | 1.69B | 1.61B | 1.61B | 1.70B | 1.42B | 1.28B | 1.18B |
| Other Expenses | 0.00 | 11.71B | 11.72B | 9.86B | 8.37B | 88.08M | 180.99M | 188.98M | 140.97M | 156.20M | 183.48M | 219.18M | 158.65M | 105.29M | 169.77M | 119.85M |
| Operating Expenses | 15.19B | 14.62B | 14.37B | 12.45B | 11.26B | 10.76B | 7.62B | 6.44B | 6.58B | 6.52B | 6.23B | 6.25B | 6.49B | 5.19B | 4.85B | 4.88B |
| Cost & Expenses | 50.86B | 48.82B | 70.09B | 63.31B | 59.53B | 58.23B | 53.14B | 50.42B | 51.25B | 49.52B | 47.91B | 47.30B | 49.29B | 47.62B | 45.86B | 48.32B |
| Interest Income | 2.01M | 2.42M | 2.52M | 1.09M | 1.60M | 1.47M | 1.83M | 1.83M | 2.34M | 5.43M | 6.09M | 4.97M | 3.83M | 2.15M | 2.69M | 5.28M |
| Interest Expense | 60.83M | 52.56M | 59.81M | 47.27M | 23.03M | 22.56M | 25.11M | 33.83M | 45.39M | 44.91M | 42.24M | 48.08M | 49.69M | 54.64M | 61.43M | 78.68M |
| Depreciation & Amortization | 2.54B | 2.42B | 2.07B | 1.53B | 838.23M | 765.70M | 758.65M | 944.27M | 946.18M | 866.53M | 779.51M | 740.99M | 713.51M | 561.24M | 512.71M | 528.87M |
| EBITDA | 4.17B | 3.90B | 5.21B | 4.27B | 3.17B | 2.77B | 2.43B | 1.53B | 1.69B | 1.89B | 2.02B | 2.18B | 2.77B | 1.32B | 635.79M | 467.26M |
| EBITDA Ratio | 8.03% | 6.05% | 5.92% | 5.12% | 5.02% | 4.57% | 9.13% | 10.47% | 9.44% | 10.38% | 10.52% | 10.83% | 10.01% | 7.07% | 5.11% | 4.70% |
| Operating Income | 1.13B | 819.90M | 2.23B | 2.04B | 2.12B | 1.85B | 1.57B | 977.03M | 559.48M | 890.52M | 1.01B | 1.13B | 1.22B | 494.56M | 300.78M | 21.16M |
| Operating Income Ratio | 2.17% | 1.65% | 3.09% | 3.11% | 3.44% | 3.08% | 2.74% | 1.77% | 1.01% | 1.64% | 1.92% | 2.17% | 2.26% | 0.98% | 0.63% | 0.04% |
| Total Other Income/Expenses | 432.22M | 598.42M | 846.21M | 554.22M | 184.02M | 130.69M | 75.12M | -1.03B | 110.42M | 44.27M | 159.14M | 237.59M | 789.38M | 210.94M | -239.12M | -161.45M |
| Income Before Tax | 1.56B | 1.42B | 3.08B | 2.59B | 2.31B | 1.98B | 1.65B | -51.69M | 669.89M | 957.27M | 1.17B | 1.36B | 2.01B | 705.49M | 61.66M | -140.29M |
| Income Before Tax Ratio | 3.00% | 2.86% | 4.26% | 3.96% | 3.74% | 3.29% | 2.87% | -0.09% | 1.21% | 1.77% | 2.22% | 2.63% | 3.73% | 1.40% | 0.13% | -0.28% |
| Income Tax Expense | 406.98M | 844.01M | 1.34B | 604.06M | 760.71M | 552.24M | 387.37M | 535.66M | 813.68M | 452.00M | 412.04M | 624.87M | 342.69M | 310.25M | 179.73M | 27.24M |
| Net Income | 1.16B | 579.60M | 1.74B | 1.98B | 1.53B | 1.41B | 1.24B | -593.25M | -143.79M | 505.28M | 754.74M | 739.42M | 1.63B | 381.34M | -118.07M | -167.53M |
| Net Income Ratio | 2.24% | 1.17% | 2.40% | 3.04% | 2.49% | 2.35% | 2.16% | -1.08% | -0.26% | 0.93% | 1.44% | 1.42% | 3.04% | 0.76% | -0.25% | -0.33% |
| EPS | 29.47 | 14.56 | 46.86 | 60.33 | 47.01 | 43.75 | 37.93 | -17.74 | -4.26 | 14.69 | 22.34 | 21.88 | 54.37 | 15.85 | -4.91 | -6.96 |
| EPS Diluted | 29.47 | 14.56 | 46.63 | 60.33 | 47.01 | 43.75 | 37.93 | -17.74 | -4.26 | 14.69 | 22.34 | 21.88 | 54.37 | 15.85 | -4.91 | -6.96 |
| Weighted Avg Shares Out | 39.46M | 39.81M | 37.06M | 32.88M | 32.61M | 32.34M | 32.74M | 33.45M | 33.76M | 33.77M | 33.78M | 33.79M | 30.04M | 24.06M | 24.07M | 24.08M |
| Weighted Avg Shares Out (Dil) | 39.46M | 39.81M | 37.25M | 32.88M | 32.61M | 32.34M | 32.74M | 33.45M | 33.76M | 33.77M | 33.78M | 33.79M | 30.04M | 24.06M | 24.07M | 24.08M |
Source: https://incomestatements.info
Category: Stock Reports